“…Liposomes are nanocarriers that are already in clinical use; they are biocompatible, and their surface and lipid wall properties can be modified in a versatile manner . Previously, light-activated release from liposomes has been achieved using gold nanoparticles as a light-triggering component. ,,, Gold nanoparticles convert absorbed light energy to heat, permeabilizing the liposomal membrane and enabling drug release to the surrounding tissue. ,,, The maximum absorption wavelength of the gold nanoparticles depends on the size and shape of the particles. − Small gold nanoparticles absorb light in the ultraviolet range (<400 nm), but such short wavelengths penetrate tissues poorly and may cause DNA damage to the cells. − Larger gold nanoparticles absorb light in the near IR range (700–900 nm), , the “phototherapeutic window”. These wavelengths are safer to the tissues and show maximal tissue penetration. , Therefore, the use of near IR light is a promising approach for light-triggered drug delivery and phototherapy. ,− …”